Hansen Technologies completes a US$24.3m block trade
Andrew Hansen has completed a US$24.3 million block trade of seven million shares in Hansen Technologies (ASX:HSN).
Hansen Technologies is an ASX-listed global software and services provider to the energy, water/utilities and telecommunications industries. The company designs and implements industry-specific software that enables energy and communications service providers to bring products to market and engage meaningfully with customers.
The share sale was decided in response to strong investor demand received following the release of the company’s FY23 results on 23 August 2023 and enables supportive investors to establish a sizeable position in Hansen in addition to enhancing the stock’s liquidity and free float.
Oaklins’ team in Australia acted as broker to Andrew Hansen to manage the sale of seven million shares in Hansen Technologies (ASX:HSN) held by the family, following the company reporting its FY23 results.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Niscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Aprenda másFairfest Media has acquired WTE Miami
Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.
Aprenda másBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Aprenda más